Who We Are
Vaniam Group is the integrated oncology organization built for what's next.
Founded in 2007. Virtual by design from day one. Built in oncology, proven across complexity. Trusted by the community we serve.
We exist to make the best decisions in oncology possible — for the biopharma teams advancing the science, the clinicians treating the disease, and the patients whose lives depend on both.
What sets us apart is what we have built. Two decades of scientific depth. Sustained engagement across the oncology community. Longitudinal insight that compounds with every program. And Vaniam Intelligence, the proprietary AI platform that turns all of it into clarity our clients can act on.
One company. One foundation. Continuously strengthening.
A purpose-driven organization.
A certified Women’s Business Enterprise (WBENC) and EcoVadis Platinum-rated for sustainability.
Vaniam Group is committed to the people advancing oncology — at our company, our clients, and across the field.
Vaniam Group operates a portfolio of specialized agencies, each with deep oncology expertise, integrated under one strategic foundation.
Our leadership
Deanna B. van Gestel, FASCO
Founder & CEO
“The oncology community is our community. Vaniam Group was built on that belief, and every engagement and every insight reflects it.“
Cherie Myatt
President
Robert Coleman, MD, FACOG, FACS
Chief Medical Officer
Steve Tulk
Chief Technology Officer
Kraig Steubing
EVP, Curio Science and Strategic Engagement
